Please have another read, this revenue has nothing to do with the Stiate+ licensing deal, it’s for all products sold for that quarter, running costs were a little higher due to increasing the size of Striate+ facility, up too 100 thousand units per year, ten more people were employed to make this happen.This information just popped up on my screen this morning
- Forums
- ASX - By Stock
- Stem Cell Therapy advancements
This information just popped up on my screen this morning
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
61.0¢ |
Change
-0.010(1.61%) |
Mkt cap ! $148.2M |
Open | High | Low | Value | Volume |
62.5¢ | 62.5¢ | 61.0¢ | $274.3K | 448.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 17378 | 61.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.5¢ | 13236 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 17953 | 0.610 |
10 | 141178 | 0.605 |
23 | 283970 | 0.600 |
1 | 6000 | 0.595 |
6 | 126224 | 0.590 |
Price($) | Vol. | No. |
---|---|---|
0.620 | 42449 | 2 |
0.625 | 21433 | 2 |
0.630 | 80528 | 4 |
0.640 | 20000 | 1 |
0.645 | 54000 | 2 |
Last trade - 11.11am 01/11/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |